Models of Prognostication in Chronic Myelomonocytic Leukemia.
- Published in:
- Current Hematologic Malignancy Reports, 2017, v. 12, n. 6, p. 513, doi. 10.1007/s11899-017-0416-8
- By:
- Publication type:
- Article
Works matching IS 15588211 AND DT 2017 AND VI 12 AND IP 6
Results: 15
1
2
Diagnostic and Prognostic Utility of Fluorescence In situ Hybridization (FISH) Analysis in Acute Myeloid Leukemia.
- Published in:
- Current Hematologic Malignancy Reports, 2017, v. 12, n. 6, p. 568, doi. 10.1007/s11899-017-0426-6
- By:
- Publication type:
- Article
3
Novel Therapies for Myelofibrosis.
- Published in:
- Current Hematologic Malignancy Reports, 2017, v. 12, n. 6, p. 611, doi. 10.1007/s11899-017-0403-0
- By:
- Publication type:
- Article
4
Methods of Detection of Measurable Residual Disease in AML.
- Published in:
- Current Hematologic Malignancy Reports, 2017, v. 12, n. 6, p. 557, doi. 10.1007/s11899-017-0419-5
- By:
- Publication type:
- Article
5
Analysis of First-Year Twitter Metrics of a Rare Disease Community for Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN) on Social Media: #BPDCN.
- Published in:
- Current Hematologic Malignancy Reports, 2017, v. 12, n. 6, p. 592, doi. 10.1007/s11899-017-0422-x
- By:
- Publication type:
- Article
6
Genome-Editing Technologies in Adoptive T Cell Immunotherapy for Cancer.
- Published in:
- Current Hematologic Malignancy Reports, 2017, v. 12, n. 6, p. 522, doi. 10.1007/s11899-017-0417-7
- By:
- Publication type:
- Article
7
Targeting IDH1 and IDH2 Mutations in Acute Myeloid Leukemia.
- Published in:
- Current Hematologic Malignancy Reports, 2017, v. 12, n. 6, p. 537, doi. 10.1007/s11899-017-0418-6
- By:
- Publication type:
- Article
8
Prognostication and Initiation of Therapy in Polycythemia Vera: Do We Have it Right?
- Published in:
- Current Hematologic Malignancy Reports, 2017, v. 12, n. 6, p. 507, doi. 10.1007/s11899-017-0423-9
- By:
- Publication type:
- Article
9
The Prognostic Significance of Measurable ('Minimal') Residual Disease in Acute Myeloid Leukemia.
- Published in:
- Current Hematologic Malignancy Reports, 2017, v. 12, n. 6, p. 547, doi. 10.1007/s11899-017-0420-z
- By:
- Publication type:
- Article
10
Rare Cancers and Social Media: Analysis of Twitter Metrics in the First 2 Years of a Rare-Disease Community for Myeloproliferative Neoplasms on Social Media-#MPNSM.
- Published in:
- Current Hematologic Malignancy Reports, 2017, v. 12, n. 6, p. 598, doi. 10.1007/s11899-017-0421-y
- By:
- Publication type:
- Article
11
Social Media in Hematology in 2017: Dystopia, Utopia, or Somewhere In-between?
- Published in:
- Current Hematologic Malignancy Reports, 2017, v. 12, n. 6, p. 582, doi. 10.1007/s11899-017-0424-8
- By:
- Publication type:
- Article
12
Novel Pathways and Potential Therapeutic Strategies for Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN): CD123 and Beyond.
- Published in:
- Current Hematologic Malignancy Reports, 2017, v. 12, n. 6, p. 510, doi. 10.1007/s11899-017-0425-7
- By:
- Publication type:
- Article
13
Using Social Media at National Meetings in Hematology-Optimal Use, Tips, Strategies, and Limitations.
- Published in:
- Current Hematologic Malignancy Reports, 2017, v. 12, n. 6, p. 605, doi. 10.1007/s11899-017-0427-5
- By:
- Publication type:
- Article
14
Measurement of Residual Disease in Acute Myeloid Leukemia.
- Published in:
- Current Hematologic Malignancy Reports, 2017, v. 12, n. 6, p. 574, doi. 10.1007/s11899-017-0428-4
- By:
- Publication type:
- Article
15
Predicting Chemotherapy Resistance in AML.
- Published in:
- Current Hematologic Malignancy Reports, 2017, v. 12, n. 6, p. 530, doi. 10.1007/s11899-017-0378-x
- By:
- Publication type:
- Article